Skip to main contentLink to External Link Policy

NIH Websites Are Changing

Beginning in late July, NIH will start introducing a new website experience designed to make it easier to find health information, research, funding opportunities, and other resources. During the transition, you may notice changes to navigation, page layouts, and where some information is located. Learn more in our Frequently Asked Questions.

Pharmacokinetic (PK) Characteristics of MG and 7-HMG

8 of 12

Runtime: 7:06

Metabolism and PK of these two constituents of kratom, and several relevant studies in rodents and in human plasma are discussed. It appears that a human-specific metabolite of 7-HMG is formed within people. The ability of these two constituents to cross the blood-brain barrier and their possible role in analgesic effects are explored. CYP enzymes and kratom’s interactions with central nervous system (CNS) drugs are relevant.